x
ServiziMenu principaleHome
You are here: Home > About us > ESO core faculty > Onco Policy
Print

Onco Policy

Matti S. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, Switzerland
Snezana M. Bosnjak, Institute of Oncology and Radiology of Serbia, Supportive Oncology & Intensive Care Unit, Belgrade, Serbia
Rolando Camacho-Rodriguez, IAEA Programme of Action for Cancer Therapy (PACT), Programme Office, Wien, Austria
Fatima Cardoso, Champalimaud Clinical Center, Breast Unit, Lisbon, Portugal
Paolo Giovanni Casali, IRCCS Foundation – National Cancer Institute, Medical oncology 2, Milan, Italy
Eduardo Cazap
, Latinamerican & Caribbean Society of Medical Oncology, Buenos Aires, Argentina
Pier Franco Conte, Oncological Center Veneto, Medical oncology dpt., Padoa, Italy
Paul Cornes, Comparative Outcomes Group, Bristol, UK
Francesco De Lorenzo, ECPC, Roma, Italy
Louis Denis, Oncology Centre Antwerp, Europa Uomo, Antwerp, Belgium
Alexandru Eniu, Cancer Institute Ion Chiricuta, Dept. of  Breast Cancer, Cluj-Napoca, Romania
Lesley Fallowfield, Brighton & Sussex Medical School, University of Sussex, SHORE-C, Brighton, United Kingdom
Margaret Foti, American Association for Cancer Research, Philadelphia, USA
Jan Geissler, CML Advocates Network, Munchen, Germany
Mary Gospodarowicz, Princess Margaret Cancer Center - University of Toronto, Dept. of Radiation Oncology, Toronto, Canada
Birgitte Grube, Danish Nurses Organisation, Nursing Professional Unit, Roskilde, Denmark
Nehmat Houssami, University of Sydney, Sydney Medical School, Sydney, Australia
Jamal Khader, King Hussein Cancer Center, Dept. of Radiation Oncology, Amman, Jordan
Claudio Lombardo, CEO of SOS Europe Srl and Director of the Organisation of the European Cancer Institutes, Genova, Italy
Rolf Marti, Swiss Cancer League, Scientific Office, Bern, Switzerland
Francesco Pignatti, European Medicines Agency, Scientific & Regulatory Management Department Oncology, Haematology & Diagnostics, London, United Kingdom
Razvan Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, Switzerland
Mahasti Saghatchian d'Assignies, Institut Gustave Roussy, Dept. of Medical Oncology, Villejuif, France
Richard Sullivan, Kings Health Partners, King's College, Integrated Cancer Centre, London, United Kingdom
Josep Tabernero, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Medical Oncology Dpt., Barcelona, Spain
Miri Ziv
, Israel Cancer Association, Director Office, Givatayim, Israel

Follow us